Evidence map›Paper›PMID 34406329›Full record

Trial reportInvestigative ophthalmology & visual science2021

Convergence Insufficiency Neuro-Mechanism Adult Population Study: Phoria Adaptation Results.

Ayushi Sangoi, Mitchell Scheiman, Chang Yaramothu, Elio M Santos, Suril Gohel, Tara L Alvarez

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Investigative ophthalmology & visual science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Objective evaluation of fusional vergence after a vision therapy protocol in typical binocular vision.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Trial
  4. Effects of vision therapy on near exodeviation in children with convergence insufficiency treated during the convergence insufficiency treatment trials.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2024
    Trial
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ayushi SangoiBiomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, United States.
Mitchell ScheimanPennsylvania College of Optometry, Salus University, Philadelphia, Pennsylvania, United States.
Chang YaramothuBiomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, United States.
Elio M SantosBiomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, United States.
Suril GohelDepartment of Health Informatics, Rutgers University School of Health Professions, Newark, New Jersey, United States.
Tara L AlvarezBiomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, United States.
New Jersey Institute of Technology · USRutgers, The State University of New Jersey · USSalus University · US

Funding

Functional Mechanisms of Neural Control in Convergence InsufficiencyR01EY023261 · NEI · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI ALVAREZ, TARA LYNN · 2014 to 2025
$4.9M
NEI NIH HHS R01 EY023261
6 · The paper itself

Abstract

Purpose: The purpose of this study was to compare changes in phoria adaptation between young adult binocularly normal controls (BNCs) and participants with symptomatic convergence insufficiency (CI), who were randomized to either office-based vergence accommodative therapy (OBVAT) or office-based placebo therapy (OBPT). Methods: In the double-masked randomized clinical trial, 50 BNC and 50 CI participants were randomized to the following therapeutic interventions: OBVAT or OBPT with home reinforcement for 12 one-hour office sessions. A 6∆ base-out and 6∆ base-in phoria adaptation experiment at near (40 cm) was conducted using the flashed Maddox rod technique at baseline and at outcome. Measurements included the rate and the magnitude of phoria adaptation. Results: At baseline, BNC and CI participants had significantly different rates and magnitudes of base-in and base-out phoria adaptation (P < 0.001). When comparing the outcome to baseline measurements, significant main effect differences in longitudinal measurements were observed for the magnitude and the rate of phoria adaptation for both base-out and base-in experiments (P < 0.05). For the magnitude and rate of phoria adaptation, post hoc analyses using paired t-tests revealed that the CI group administered the OBVAT intervention exhibited a significant increase in the magnitude and rate of phoria adaptation compared to baseline for both base-in and base-out phoria adaptation (P < 0.01) but not for those administered OBPT. Conclusions: Phoria adaptation is significantly different at baseline between those with normal binocular vision and symptomatic CI participants. OBVAT significantly improves the rate and magnitude of both base-out and base-in phoria adaptation at near compared to OBPT. Results have clinical implications for new therapeutic interventions.

Indexed as

Accommodation, OcularAdolescentAdultConvergence, OcularDouble-Blind MethodFemaleFollow-Up StudiesHumansMaleOcular Motility DisordersStrabismusVision, BinocularYoung Adult

Identifiers

PMID34406329
PMCPMC8374988
OpenAlexW3193371159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.